The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression

BACKGROUND: Patients with hepatocellular carcinoma (HCC) have poor prognosis, especially in advanced stages. Targeted therapy is the main treatment for advanced HCC patients, but the optimal targets for HCC remain poorly understood. The main purpose of this study was to identify potential novel prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Zhongyuan, Wang, Jielong, Chen, Gang, Li, Dongliang, Cheng, Bianqiao, Lai, Yanhua, Wu, Zhixian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869145/
https://www.ncbi.nlm.nih.gov/pubmed/36698420
http://dx.doi.org/10.3389/fonc.2022.1081510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869145/
https://www.ncbi.nlm.nih.gov/pubmed/36698420
http://dx.doi.org/10.3389/fonc.2022.1081510

Ejemplares similares